Critical Therapeutics to Present at Upcoming Biotechnology and Healthc

Critical Therapeutics to Present at Upcoming Biotechnology and Healthcare Investor Conferences

    Business Editors
    JPMorgan Annual Healthcare Conference 2005
    Piper Jaffray Health Care Conference

    LEXINGTON, Mass.--(BUSINESS WIRE)--Jan. 3, 2005--Critical Therapeutics, Inc. (NASDAQ: CRTX), a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases, today announced that its senior management is scheduled to present at the following investor conferences in January:

--	JPMorgan Healthcare Conference - 10:30 a.m. PT/1:30 p.m. ET on Thursday, January 13 from The Westin St. Francis Hotel in San Francisco.
--	Piper Jaffray Health Care Conference - 1:30 p.m. ET on Wednesday, January 26 from The Pierre New York Hotel in New York.

    Live and archived audio webcasts of these presentations will be available by logging on to the "Investors" section of the Company's website, www.crtx.com, and clicking the link labeled "Webcasts & Presentations."

    About Critical Therapeutics

    Critical Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. The Company is developing a sales and marketing infrastructure in connection with its in-licensed product, Zyflo(R), a tablet formulation of zileuton. Critical Therapeutics also is developing treatments directed toward the severe inflammatory response in acute diseases and conditions that lead to admission to the emergency room or intensive care unit, and acute exacerbations of other chronic diseases that frequently lead to hospitalization. For more information, please visit www.crtx.com.

--30--DC/bo*

CONTACT: Critical Therapeutics Inc. Linda Lennox, 781-402-5700 llennox@crtx.com

KEYWORD: CALIFORNIA MASSACHUSETTS NEW YORK INDUSTRY KEYWORD: PHARMACEUTICAL BIOTECHNOLOGY TRADESHOW CONFERENCE CALLS SOURCE: Critical Therapeutics, Inc.

Copyright Business Wire 2005